Inhibikase Therapeutics, Inc. - IKT

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$200.8M

QoQ value delta ($000)

-$75.61M (-27.36%)

Implied price effect (QoQ)

-34.79%

Total shares

118,553,555

QoQ shares delta

+12,138,220 (+11.41%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 104 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
Sands Capital Alternatives, LLC	21,871	13,018,965	5.19%
Soleus Capital Management, L.P.	18,270	10,875,000	0.74%
Fairmount Funds Management LLC	14,490	8,625,000	1.05%
Trails Edge Capital Partners, LP	13,536	8,057,345	3.1%
ADAR1 Capital Management, LLC	11,099	6,606,572	0.65%
BlackRock, Inc.	10,589	6,303,433	0.0%
Blackstone Inc.	9,976	5,938,276	0.04%
Siren, L.L.C.	9,828	5,850,000	0.27%
VANGUARD GROUP INC	9,345	4,558,604	0.0%
Commodore Capital LP	9,067	5,397,488	0.52%
VANGUARD CAPITAL MANAGEMENT LLC	7,477	4,450,665	0.0%
Saturn V Capital Management LP	6,490	3,863,445	1.18%
Spruce Street Capital LP	6,017	3,581,603	1.45%
Squadron Capital Management LLC	5,880	3,500,000	2.15%
MILLENNIUM MANAGEMENT LLC	4,919	2,928,077	0.0%
Nantahala Capital Management, LLC	4,539	2,701,863	0.17%
Kalehua Capital Management LLC	4,489	2,672,608	3.78%
PERCEPTIVE ADVISORS LLC	3,889	2,315,000	0.08%
GEODE CAPITAL MANAGEMENT, LLC	3,646	2,170,186	0.0%
STATE STREET CORP	2,832	1,685,816	0.0%
SummitTX Capital, L.P.	2,561	1,524,536	0.08%
Integral Health Asset Management, LLC	2,268	1,350,000	0.11%
Ally Bridge Group (NY) LLC	2,226	1,325,000	1.8%
CITADEL ADVISORS LLC	1,852	1,102,585	0.0%
Stonepine Capital Management, LLC	1,608	957,202	0.64%